Loading…

5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease

The aim of this study was to compare 5-year cardiovascular, renal, and bioprosthetic valve durability outcomes in patients with severe aortic stenosis (AS) and chronic kidney disease (CKD) undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR). Patients...

Full description

Saved in:
Bibliographic Details
Published in:JACC. Cardiovascular interventions 2021-09, Vol.14 (18), p.1995-2005
Main Authors: Garcia, Santiago, Cubeddu, Robert J, Hahn, Rebecca T, Ternacle, Julien, Kapadia, Samir R, Kodali, Susheel K, Thourani, Vinod H, Jaber, Wael A, Asher, Craig R, Elmariah, Sammy, Makkar, Raj, Webb, John G, Herrmann, Howard C, Lu, Michael, Devireddy, Chandan M, Malaisrie, S Chris, Smith, Craig R, Mack, Michael J, Sorajja, Paul, Cavalcante, João L, Goessl, Mario, Shroff, Gautam R, Leon, Martin B, Pibarot, Philippe
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to compare 5-year cardiovascular, renal, and bioprosthetic valve durability outcomes in patients with severe aortic stenosis (AS) and chronic kidney disease (CKD) undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR). Patients with severe AS and CKD undergoing TAVR or SAVR are a challenging, understudied clinical subset. Intermediate-risk patients with moderate to severe CKD (estimated glomerular filtration rate 
ISSN:1936-8798
1876-7605
DOI:10.1016/j.jcin.2021.07.004